Blood cancers

Haematological cancers linked to four-fold higher risk of COVID-19 death

Recent haematological malignancy is a clinical risk factor for death from COVID-19 disease identified in an analysis of data from patients in a UK database. Patients with haematological malignancy up to five years from diagnosis had up to a four-fold increased risk of dying in hospital with COVID-19 compared to those without blood cancer history ...

Already a member?

Login to keep reading.

© 2020 the limbic